Marlin Squeeze Bottle & Marlin Salt Tablets
PMA P800038
Active
Valid until
No expiry
FDA recalls
None foundDocuments
Trust
Unverified
Regulatory status
| Region | Authorization | Number | Date | Status |
|---|---|---|---|---|
| United States | FDA PMAAPPR | NumberP800038 | Date4 Oct 1982 | StatusActive |
Recalls
No FDA recalls found in the data synced 22 Oct 2026.
Coverage
- Active
- Expiring
- Withdrawn
- Listed
- Not covered
United States — FDA PMA Active
Specification
- Generic Name
- Accessories, soft lens products
- PMA Number
- FDA Product Code
- LPN
- Device Class
- Class II
- Regulation
- 21 CFR Part 886.5928
- Advisory Committee
- Ophthalmic
- FDA Decision
- APPR Approved
- PMA Supplement
- S001
Overview
AI-generated summary, 18 Sep 2026
The Marlin Squeeze Bottle & Marlin Salt Tablets are classified as Accessories, Soft Lens Products, designed to facilitate the storage and handling of contact lens solutions. This system combines a squeeze bottle for dispensing saline or solution with salt tablets that dissolve to create a sterile saline solution, ensuring proper lens care and maintenance for ophthalmic use.
This device is intended for single-use or reusable applications in ophthalmic settings, with FDA Premarket Approval (PMA P800038). The squeeze bottle and salt tablets are supplied as a combined system, adhering to regulatory standards for ophthalmic accessories. Storage and handling must comply with sterile or clean-room protocols as specified in FDA guidance under regulation number 886.5928.
Other devices from Marlin Industries
Questions
AI-generated answers, 18 Sep 2026
What is the primary purpose of the Marlin Squeeze Bottle & Marlin Salt Tablets in ophthalmic care?
The Marlin Squeeze Bottle & Marlin Salt Tablets are designed as an accessory system for soft lens products, specifically to facilitate the storage and handling of contact lens solutions. The squeeze bottle dispenses saline or solution, while the salt tablets dissolve to create a sterile saline solution, ensuring proper lens care and maintenance in ophthalmic settings.
How should the Marlin Squeeze Bottle & Marlin Salt Tablets be stored and handled?
Storage and handling of the Marlin Squeeze Bottle & Marlin Salt Tablets must comply with sterile or clean-room protocols, as outlined in FDA guidance under regulation number 886.5928. This ensures the integrity of the system for ophthalmic use, particularly when used for single-use or reusable applications.
Are the Marlin Squeeze Bottle and Marlin Salt Tablets intended for single-use or reusable applications?
The Marlin Squeeze Bottle & Marlin Salt Tablets are explicitly designed for both single-use and reusable applications in ophthalmic settings, depending on the clinical workflow and compliance with sterile handling protocols.
What regulatory pathway was followed for the approval of the Marlin Squeeze Bottle & Marlin Salt Tablets?
The device received FDA Premarket Approval (PMA) under the designation P800038, indicating it underwent a rigorous review process to ensure safety and effectiveness as an accessory for soft lens products in ophthalmic use.
How is the Marlin Squeeze Bottle & Marlin Salt Tablets system supplied, and what does it include?
The system is supplied as a combined unit, consisting of a squeeze bottle for dispensing saline or solution and Marlin Salt Tablets that dissolve to create a sterile saline solution. This integrated approach ensures proper lens care and maintenance for ophthalmic applications.